The Prague Post - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.313437
AFN 77.857768
ALL 96.703218
AMD 448.16276
ANG 2.102869
AOA 1077.037474
ARS 1701.589707
AUD 1.77257
AWG 2.114141
AZN 1.996589
BAM 1.960612
BBD 2.364091
BDT 143.434086
BGN 1.95915
BHD 0.442807
BIF 3469.968474
BMD 1.174523
BND 1.516852
BOB 8.110595
BRL 6.464101
BSD 1.173731
BTN 106.15401
BWP 15.502387
BYN 3.465959
BYR 23020.642557
BZD 2.360764
CAD 1.617065
CDF 2642.675402
CHF 0.933781
CLF 0.027416
CLP 1075.240079
CNY 8.270929
CNH 8.265479
COP 4522.252542
CRC 584.810379
CUC 1.174523
CUP 31.124848
CVE 110.530152
CZK 24.389545
DJF 209.014076
DKK 7.47142
DOP 73.879747
DZD 152.062996
EGP 55.868526
ERN 17.617839
ETB 182.474348
FJD 2.677321
FKP 0.874908
GBP 0.879089
GEL 3.165363
GGP 0.874908
GHS 13.521668
GIP 0.874908
GMD 86.326653
GNF 10261.616743
GTQ 8.989795
GYD 245.572243
HKD 9.137386
HNL 30.92524
HRK 7.536562
HTG 153.744055
HUF 387.819086
IDR 19613.352554
ILS 3.784282
IMP 0.874908
INR 106.148829
IQD 1537.641036
IRR 49473.820201
ISK 148.002083
JEP 0.874908
JMD 187.820961
JOD 0.832774
JPY 182.596565
KES 151.289863
KGS 102.712187
KHR 4701.338151
KMF 493.299913
KPW 1057.083725
KRW 1729.731568
KWD 0.36032
KYD 0.978159
KZT 603.725997
LAK 25425.074943
LBP 105110.240336
LKR 363.524444
LRD 207.75103
LSL 19.658244
LTL 3.468059
LVL 0.710457
LYD 6.364457
MAD 10.755255
MDL 19.806768
MGA 5302.947067
MKD 61.559811
MMK 2466.755122
MNT 4167.704906
MOP 9.404882
MRU 46.668749
MUR 54.086853
MVR 18.099226
MWK 2035.308525
MXN 21.11865
MYR 4.802036
MZN 75.063039
NAD 19.657909
NGN 1710.187282
NIO 43.193433
NOK 11.982784
NPR 169.842268
NZD 2.029428
OMR 0.451607
PAB 1.173766
PEN 3.953985
PGK 4.990952
PHP 68.810593
PKR 328.893388
PLN 4.208655
PYG 7884.047408
QAR 4.278865
RON 5.093086
RSD 117.375881
RUB 94.136416
RWF 1709.021623
SAR 4.405285
SBD 9.588099
SCR 15.848316
SDG 706.479603
SEK 10.912032
SGD 1.515581
SHP 0.881196
SLE 27.948604
SLL 24629.155534
SOS 669.597756
SRD 45.428227
STD 24310.246043
STN 24.559229
SVC 10.270638
SYP 12986.879782
SZL 19.653398
THB 36.940491
TJS 10.833774
TMT 4.122574
TND 3.425634
TOP 2.827969
TRY 50.180409
TTD 7.962202
TWD 36.949896
TZS 2899.838734
UAH 49.820151
UGX 4184.072857
USD 1.174523
UYU 45.729897
UZS 14209.328927
VES 320.931369
VND 30931.05213
VUV 142.502152
WST 3.278127
XAF 657.542787
XAG 0.01778
XAU 0.00027
XCD 3.174206
XCG 2.115447
XDR 0.815677
XOF 657.551205
XPF 119.331742
YER 279.94736
ZAR 19.614609
ZMK 10572.114496
ZMW 26.908008
ZWL 378.195791
  • CMSC

    -0.0770

    23.263

    -0.33%

  • RIO

    1.1890

    77.179

    +1.54%

  • SCS

    0.0200

    16.14

    +0.12%

  • BCC

    -0.0300

    75.81

    -0.04%

  • CMSD

    -0.0800

    23.3

    -0.34%

  • BTI

    0.1750

    57.465

    +0.3%

  • RBGPF

    0.4100

    82.01

    +0.5%

  • BCE

    -0.0170

    23.313

    -0.07%

  • RYCEF

    0.1200

    14.92

    +0.8%

  • JRI

    -0.0940

    13.416

    -0.7%

  • NGG

    1.1900

    76.96

    +1.55%

  • VOD

    0.1100

    12.81

    +0.86%

  • BP

    0.5250

    34.285

    +1.53%

  • AZN

    -0.3600

    90.99

    -0.4%

  • RELX

    0.0350

    40.855

    +0.09%

  • GSK

    0.4100

    49.19

    +0.83%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

J.Simacek--TPP